The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Tissue Microarray Market At The End Of The 2026–2030 Forecast Period?
The tissue microarray market has witnessed substantial growth in recent years. Its valuation is anticipated to climb from $13.11 billion in 2025 to $14.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.0%. This historical expansion can be linked to factors such as an increase in cancer research efforts, the broader implementation of immunohistochemistry techniques, the development of academic pathology research, a growing need for biomarker validation tools, and the accessibility of paraffin-embedded tissue samples.
The tissue microarray market is projected to experience substantial expansion in the coming years, with its value expected to escalate to $23.61 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is primarily driven by factors such as enhanced investment in precision oncology research, the increasing integration of digital pathology solutions, the proliferation of translational research initiatives, a rising need for multi-omics analysis, and the expanding application of tissue microarrays in the field of drug discovery. Key trends anticipated for this period encompass the greater utilization of high-throughput tissue analysis platforms, a growing embrace of multiplex immunohistochemistry, an escalating requirement for standardized tissue arrays, the broader implementation of automated tissue microarray construction, and improved incorporation with molecular diagnostics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Tissue Microarray Market?
The increasing demand for personalized medicine is expected to stimulate the expansion of the tissue microarray market moving forward. Personalized medicine involves customizing medical treatment to an individual’s specific characteristics, aiming for more effective and precise healthcare outcomes. Within personalized medicine, tissue microarrays are utilized to concurrently analyze multiple tissue samples, allowing for the rapid and efficient assessment of biomarkers to guide tailored patient treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the USFDA approved 16 new personalized treatments for rare disease patients in 2023, marking a significant increase from the 6 personalized treatments approved in 2022. Thus, the growing demand for personalized medicine is a key factor propelling the growth of the tissue microarray market.
What Segment Types Make Up The Tissue Microarray Market?
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Immunohistochemistry (IHC)–Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies
3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array
Which Market Trends Are Creating New Opportunities In The Tissue Microarray Market?
Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that facilitates simultaneous analysis of multiple genes or other biomolecules on a small surface, thereby enabling genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2. This advanced microarray platform was funded by the Carlos III Health Institute (ISCIII) and the European Union’s NextGenerationEU initiative. It stands as the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, having attained IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.
Who Are The Key Players Driving Competition In The Tissue Microarray Market?
Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.
Read the full tissue microarray market report here:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
Which Regions Are Projected To Dominate The Tissue Microarray Market In The Coming Years?
North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tissue Microarray Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp
Browse Through More Reports Similar to the Global Tissue Microarray Market 2026, By The Business Research Company
Microarray Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-global-market-report
Dna Microarray Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report
Microarray Scanners Market Report 2026
https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model